Manufacturing, researching & developing pharmaceuticals from Northumberland to the world
Northumberland is the location of many pharmaceutical healthcare and life sciences businesses.
A VIBRANT & DIVERSE CLUSTER
Leading companies in life sciences, pharma and healthcare businesses who call Northumberland home include Piramal Healthcare, Legrand Tynetech, ThermoFisher Scientific, Femeda, Quotient Sciences, Organon and Pharmaron.
From manufacturing of critical medications to research and development, in urban locations such as Cramlington and Blyth to rural locations like Alnwick Northumberland operates across the health and life sciences field and offers opportunities for investment across the county.
A STRONG NORTH EAST ECOSYSTEM
The wider North East area is recognised for its established and dynamic pharmaceutical and life sciences industry including manufacturing, medical devices, assistive technology and health informatics that inject energy and creativity into the cluster.
All of these areas underpinned by strong cluster networks including Bionow, NEPIC and First for Pharma, hospital trusts and research translation organisations as well as a strong university presence from five globally recognised universities.
Companies investing into the County benefit from an established ecosystem, access to support and expertise to drive forward new global opportunities from Northumberland.
NORTH EAST HEALTH CARE & LIFE SCIENCES STATS
125
Undergraduate and postgraduate courses related to the life science sector across the 5 NE Universities
HOME TO
Top ranked life science assets for R&D such as The Centre for Life, CPI, The National Innovation Centre for Ageing and The NIHR Newcastle Biomedical Research Centre.
CLUSTER
Industry led business network NEPIC membership organisation supporting the region's chemistry using industries
2nd
Leading destination for Life Science FDI based on capital expenditure figures, attracting about a fifth (18%) of all UK life science FDI projects
“It is an absolute privilege to work in Northumberland, developing medicines to ultimately benefit patients as well as being part of a community where we can share our interests in science.”
This website uses cookies to ensure you get the best experience on our website. Please let us know your preferences.
